Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Venetoclax and Posaconazole Plus Standard Dose Cytarabine or Azacytidine for Newly Diagnosed Acute Myeloid Leukemia

Tran-Der Tan, MD, Lun-Wei Chiou, MD

Blood (2020) 136 (Supplement 1): 41.

https://doi.org/10.1182/blood-2020-142409

Published: 2020

Journal Articles

Characteristics and Treatment Response of Newly Diagnosed Advanced-Stage and Relapsed/Refractory Hodgkin Lymphoma in Taiwan: A Nationwide Retrospective Study

Chieh-Lin Jerry Teng, Tran-Der Tan, MD, Yu-Wen Lin, Pei-Wen Lien, Hsin-Chun Chou, Fang-Ju Lin

Blood (2020) 136 (Supplement 1): 30.

https://doi.org/10.1182/blood-2020-141186

Published: 2020

Journal Articles

Failure Pattern of Treatment of Hodgkin Lymphoma -- Retrospective from a Single Institution

Tran-Der Tan, MD, Lun-Wei Chiou, MD

Blood (2016) 128 (22): 5366.

https://doi.org/10.1182/blood.V128.22.5366.5366

Published: 2016

Journal Articles

Safety and Efficacy of Nilotinib (NIL) in Patients (Pts) with Chronic Phase (CP) or Accelerated Phase (AP) Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML) with Resistance or Intolerance to Imatinib Mesylate (IM): Results from the Multicenter, Observational NOVEL Study in Taiwan

Ching-Yuan Kuo, MD, Po-Nan Wang, MD, Wen Li Hwang, MD, Cheng-Hwai Tzeng, MD, Li-Yuan Bai, MD, Jih-Luh Tang, MD PhD, Ming-Chih Chang, MD, Sheng-Fung Lin, MD, Tsai-Yun Chen, MD, Yeu-Chin Chen, MD, Tran-Der Tan, MD, Chih-Yi Hseih, MD, Chinjune Lin, MD, Miljkovic Darko, MD, Chang Cheng-Shyong, MD

Blood (2015) 126 (23): 1593.

https://doi.org/10.1182/blood.V126.23.1593.1593

Published: 2015

Journal Articles

CD56-Positive Acute Myeloid Leukemia Has Inferior Outcome After Allogeneic Hematopoietic Stem Cell Transplantation

Tran-Der Tan, MD, Mau-Ching Wu, MD, PhD, Lun-Wei Chiou, MD

Blood (2011) 118 (21): 4493.

https://doi.org/10.1182/blood.V118.21.4493.4493

Published: 2011

Journal Articles

A National Registry of Patients Diagnosed with Multiple Myeloma in Taiwan.

Tzeon-Jye Chiou, MD, Shang-Yi Huang, MD, PhD, Cheng-Shyong Chang, MD, Sheng-Fung Lin, MD, Sung-Nan Pei, MD, Chang-Fang Chiu, MD, DMS, Ching-Liang Ho, Ming-Chih Chang, MD, Tran-Der Tan, MD, Liang-Tsai Hsiao, MD

Blood (2009) 114 (22): 4955.

https://doi.org/10.1182/blood.V114.22.4955.4955

Published: 2009

NARROW

Venetoclax and Posaconazole Plus Standard Dose Cytarabine or Azacytidine for Newly Diagnosed Acute Myeloid Leukemia

Characteristics and Treatment Response of Newly Diagnosed Advanced-Stage and Relapsed/Refractory Hodgkin Lymphoma in Taiwan: A Nationwide Retrospective Study

Failure Pattern of Treatment of Hodgkin Lymphoma -- Retrospective from a Single Institution

CD56-Positive Acute Myeloid Leukemia Has Inferior Outcome After Allogeneic Hematopoietic Stem Cell Transplantation

A National Registry of Patients Diagnosed with Multiple Myeloma in Taiwan.

Email alerts

ASH Publications

American Society of Hematology

Venetoclax and Posaconazole Plus Standard Dose Cytarabine or Azacytidine for Newly Diagnosed Acute Myeloid Leukemia

Characteristics and Treatment Response of Newly Diagnosed Advanced-Stage and Relapsed/Refractory Hodgkin Lymphoma in Taiwan: A Nationwide Retrospective Study

Failure Pattern of Treatment of Hodgkin Lymphoma -- Retrospective from a Single Institution

CD56-Positive Acute Myeloid Leukemia Has Inferior Outcome After Allogeneic Hematopoietic Stem Cell Transplantation

A National Registry of Patients Diagnosed with Multiple Myeloma in Taiwan.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only